Causeway Medicine Internal is categorized under Nonclassified Establishments in Metairie, LA and active since 2012.
Causeway Medicine Internal was established in 2012, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Nonclassified Establishments business, which does work in the BOTH market, and is classified as a Nonclassified Establishments, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Robert D Lesser at the company’s single location by writing to 3749 North Causeway Boulevard, Metairie, Louisiana LA 70002 or by phoning (504) 828-8241. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Causeway Medicine Internal |
Contact Person: | Robert D Lesser |
Address: | 3749 North Causeway Boulevard, Metairie, Louisiana 70002 |
Phone Number: | (504) 828-8241 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Nonclassified Establishments |
SIC Code: | 9999 |
NAICS Code: | 6211110 |
Share This Business: |
Causeway Medicine Internal was started in 2012 to provide professional Nonclassified Establishments under the SIC code 9999 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Robert D Lesser for inquiries that concern Causeway Medicine Internal by calling the company number (504) 828-8241, as your correspondence is most welcome. Additionally, the physical location of the single location of Causeway Medicine Internal can be found at the coordinates 30.016217,-90.154644 as well as the street address 3749 North Causeway Boulevard in Metairie, Louisiana 70002.
For its online presence, you may visit Causeway Medicine Internal’s website at and engage with its social media outlets through on Twitter and on Facebook.